期刊
DIABETES
卷 62, 期 2, 页码 327-335出版社
AMER DIABETES ASSOC
DOI: 10.2337/db12-1326
关键词
-
资金
- National Institute of Diabetes and Digestive and Kidney Diseases [DK059579, DK061539, DK077967]
- Larry L. Hillblom Foundation
- National Institutes of Health [AG027936]
The islet in type 2 diabetes (T2DM) is characterized by a deficit in beta-cells, increased beta-cell apoptosis, and extracellular amyloid deposits derived from islet amyloid polypeptide (IAPP). In the absence of longitudinal studies, it is unknown if the low beta-cell mass in T2DM precedes diabetes onset (is a risk factor for diabetes) or develops as a consequence of the disease process. Although insulin resistance is a risk factor for T2DM, most individuals who are insulin resistant do not develop diabetes. By inference, an increased beta-cell workload results in T2DM in some but not all individuals. We propose that the extent of the beta-cell mass that develops during childhood may underlie subsequent successful or failed adaptation to insulin resistance in later life. We propose that a low innate beta-cell mass in the face of subsequent insulin resistance may expose beta-cells to a burden of insulin and TAPP biosynthetic demand that exceeds the cellular capacity for protein folding and trafficking. If this threshold is crossed, intracellular toxic IAPP membrane permeant oligomers (cylindrins) may form, compromising beta-cell function and inducing beta-cell apoptosis. Diabetes 62:327-335, 2013
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据